HEADER TRANSFERASE 20-SEP-23 8QLQ TITLE HUMAN MST3 (STK24) KINASE IN COMPLEX WITH MACROCYCLIC INHIBITOR JA310 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE 24; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAMMALIAN STE20-LIKE PROTEIN KINASE 3,MST-3,STE20-LIKE COMPND 5 KINASE MST3; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: STK24, MST3, STK3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SELECTIVE KINASE INHIBITORS, MACROCYCLIC INHIBITORS, STRUCTURE-GUIDED KEYWDS 2 DRUG DESIGN, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR D.I.BALOURDAS,J.A.AMRHEIN,T.HANKE,S.KNAPP,A.C.JOERGER,STRUCTURAL AUTHOR 2 GENOMICS CONSORTIUM (SGC) REVDAT 2 29-MAY-24 8QLQ 1 JRNL REVDAT 1 08-NOV-23 8QLQ 0 JRNL AUTH J.A.AMRHEIN,L.M.BERGER,D.I.BALOURDAS,A.C.JOERGER,A.MENGE, JRNL AUTH 2 A.KRAMER,J.M.FRISCHKORN,B.T.BERGER,L.ELSON,A.KAISER, JRNL AUTH 3 M.SCHUBERT-ZSILAVECZ,S.MULLER,S.KNAPP,T.HANKE JRNL TITL SYNTHESIS OF PYRAZOLE-BASED MACROCYCLES LEADS TO A HIGHLY JRNL TITL 2 SELECTIVE INHIBITOR FOR MST3. JRNL REF J.MED.CHEM. V. 67 674 2024 JRNL REFN ISSN 0022-2623 JRNL PMID 38126712 JRNL DOI 10.1021/ACS.JMEDCHEM.3C01980 REMARK 2 REMARK 2 RESOLUTION. 1.64 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10.1_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.64 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.50 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.344 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 3 NUMBER OF REFLECTIONS : 37359 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.181 REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.078 REMARK 3 FREE R VALUE TEST SET COUNT : 1897 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 42.5000 - 3.9517 0.96 2667 163 0.1708 0.1871 REMARK 3 2 3.9517 - 3.1369 0.99 2649 139 0.1614 0.2109 REMARK 3 3 3.1369 - 2.7404 1.00 2627 134 0.1780 0.2114 REMARK 3 4 2.7404 - 2.4899 0.99 2598 118 0.1707 0.2698 REMARK 3 5 2.4899 - 2.3114 0.94 2443 149 0.1597 0.2373 REMARK 3 6 2.3114 - 2.1752 0.99 2562 125 0.1649 0.2239 REMARK 3 7 2.1752 - 2.0662 0.98 2537 132 0.1725 0.2281 REMARK 3 8 2.0662 - 1.9763 0.98 2520 124 0.1797 0.2504 REMARK 3 9 1.9763 - 1.9002 0.99 2551 134 0.2081 0.2512 REMARK 3 10 1.9002 - 1.8346 0.98 2498 143 0.2203 0.2706 REMARK 3 11 1.8346 - 1.7773 0.96 2470 142 0.2266 0.2684 REMARK 3 12 1.7773 - 1.7265 0.96 2485 117 0.2335 0.2891 REMARK 3 13 1.7265 - 1.6810 0.93 2380 138 0.2499 0.2795 REMARK 3 14 1.6810 - 1.6400 0.98 2475 139 0.2819 0.3393 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.206 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.671 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.73 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.34 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 2279 REMARK 3 ANGLE : 0.823 3090 REMARK 3 CHIRALITY : 0.050 346 REMARK 3 PLANARITY : 0.005 414 REMARK 3 DIHEDRAL : 14.916 1383 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8QLQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-SEP-23. REMARK 100 THE DEPOSITION ID IS D_1292133418. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-SEP-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37428 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.640 REMARK 200 RESOLUTION RANGE LOW (A) : 42.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.64 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.67 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.2 REMARK 200 DATA REDUNDANCY IN SHELL : 6.30 REMARK 200 R MERGE FOR SHELL (I) : 0.71900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.38 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN SOLUTION: 11 MG/ML MST3 IN 25 REMARK 280 MM HEPES PH 7.5, 200 MM NACL, 0.5 MM TCEP, 5% GLYCEROL) WITH 3 REMARK 280 MM MACROCYCLIC INHIBITOR JA310. RESERVOIR SOLUTION: 14% PEG 6K, REMARK 280 0.1 M HEPES PH 7.2. DROP RATIO 1:2., VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 19.06350 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 50.26850 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.87650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 50.26850 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 19.06350 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.87650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 3 REMARK 465 ARG A 4 REMARK 465 ALA A 5 REMARK 465 GLN A 6 REMARK 465 LEU A 7 REMARK 465 TRP A 8 REMARK 465 GLY A 9 REMARK 465 LEU A 10 REMARK 465 ALA A 11 REMARK 465 LEU A 12 REMARK 465 ASN A 13 REMARK 465 LYS A 14 REMARK 465 ARG A 15 REMARK 465 ARG A 16 REMARK 465 ALA A 17 REMARK 465 THR A 18 REMARK 465 LEU A 19 REMARK 465 PRO A 20 REMARK 465 HIS A 21 REMARK 465 PRO A 22 REMARK 465 GLY A 23 REMARK 465 GLY A 24 REMARK 465 SER A 25 REMARK 465 GLU A 73 REMARK 465 ASP A 74 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 26 N CA CB OG1 CG2 REMARK 470 LEU A 28 CG CD1 CD2 REMARK 470 LYS A 29 CG CD CE NZ REMARK 470 LYS A 41 CG CD CE NZ REMARK 470 LYS A 44 CG CD CE NZ REMARK 470 ARG A 57 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 60 CD CE NZ REMARK 470 GLU A 70 CG CD OE1 OE2 REMARK 470 GLU A 71 CG CD OE1 OE2 REMARK 470 GLU A 75 CG CD OE1 OE2 REMARK 470 ILE A 76 CG1 CG2 CD1 REMARK 470 ASP A 78 CG OD1 OD2 REMARK 470 ASP A 104 CG OD1 OD2 REMARK 470 LYS A 292 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 39 -144.37 -99.04 REMARK 500 PHE A 47 -2.49 70.33 REMARK 500 ASP A 104 -116.23 58.60 REMARK 500 ARG A 155 -1.45 73.37 REMARK 500 ASP A 156 46.18 -140.82 REMARK 500 ASP A 209 -158.80 -141.57 REMARK 500 REMARK 500 REMARK: NULL DBREF 8QLQ A 4 301 UNP Q9Y6E0 STK24_HUMAN 4 301 SEQADV 8QLQ MET A 3 UNP Q9Y6E0 INITIATING METHIONINE SEQADV 8QLQ ALA A 302 UNP Q9Y6E0 EXPRESSION TAG SEQADV 8QLQ HIS A 303 UNP Q9Y6E0 EXPRESSION TAG SEQADV 8QLQ HIS A 304 UNP Q9Y6E0 EXPRESSION TAG SEQADV 8QLQ HIS A 305 UNP Q9Y6E0 EXPRESSION TAG SEQADV 8QLQ HIS A 306 UNP Q9Y6E0 EXPRESSION TAG SEQADV 8QLQ HIS A 307 UNP Q9Y6E0 EXPRESSION TAG SEQADV 8QLQ HIS A 308 UNP Q9Y6E0 EXPRESSION TAG SEQRES 1 A 306 MET ARG ALA GLN LEU TRP GLY LEU ALA LEU ASN LYS ARG SEQRES 2 A 306 ARG ALA THR LEU PRO HIS PRO GLY GLY SER THR ASN LEU SEQRES 3 A 306 LYS ALA ASP PRO GLU GLU LEU PHE THR LYS LEU GLU LYS SEQRES 4 A 306 ILE GLY LYS GLY SER PHE GLY GLU VAL PHE LYS GLY ILE SEQRES 5 A 306 ASP ASN ARG THR GLN LYS VAL VAL ALA ILE LYS ILE ILE SEQRES 6 A 306 ASP LEU GLU GLU ALA GLU ASP GLU ILE GLU ASP ILE GLN SEQRES 7 A 306 GLN GLU ILE THR VAL LEU SER GLN CYS ASP SER PRO TYR SEQRES 8 A 306 VAL THR LYS TYR TYR GLY SER TYR LEU LYS ASP THR LYS SEQRES 9 A 306 LEU TRP ILE ILE MET GLU TYR LEU GLY GLY GLY SER ALA SEQRES 10 A 306 LEU ASP LEU LEU GLU PRO GLY PRO LEU ASP GLU THR GLN SEQRES 11 A 306 ILE ALA THR ILE LEU ARG GLU ILE LEU LYS GLY LEU ASP SEQRES 12 A 306 TYR LEU HIS SER GLU LYS LYS ILE HIS ARG ASP ILE LYS SEQRES 13 A 306 ALA ALA ASN VAL LEU LEU SER GLU HIS GLY GLU VAL LYS SEQRES 14 A 306 LEU ALA ASP PHE GLY VAL ALA GLY GLN LEU THR ASP THR SEQRES 15 A 306 GLN ILE LYS ARG ASN THR PHE VAL GLY THR PRO PHE TRP SEQRES 16 A 306 MET ALA PRO GLU VAL ILE LYS GLN SER ALA TYR ASP SER SEQRES 17 A 306 LYS ALA ASP ILE TRP SER LEU GLY ILE THR ALA ILE GLU SEQRES 18 A 306 LEU ALA ARG GLY GLU PRO PRO HIS SER GLU LEU HIS PRO SEQRES 19 A 306 MET LYS VAL LEU PHE LEU ILE PRO LYS ASN ASN PRO PRO SEQRES 20 A 306 THR LEU GLU GLY ASN TYR SER LYS PRO LEU LYS GLU PHE SEQRES 21 A 306 VAL GLU ALA CYS LEU ASN LYS GLU PRO SER PHE ARG PRO SEQRES 22 A 306 THR ALA LYS GLU LEU LEU LYS HIS LYS PHE ILE LEU ARG SEQRES 23 A 306 ASN ALA LYS LYS THR SER TYR LEU THR GLU LEU ILE ASP SEQRES 24 A 306 ALA HIS HIS HIS HIS HIS HIS HET VY0 A 401 25 HET EDO A 402 4 HETNAM VY0 MACROCYCLIC INHIBITOR HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 2 VY0 C17 H19 N7 O FORMUL 3 EDO C2 H6 O2 FORMUL 4 HOH *236(H2 O) HELIX 1 AA1 ASP A 31 LEU A 35 1 5 HELIX 2 AA2 ILE A 76 SER A 87 1 12 HELIX 3 AA3 ALA A 119 LEU A 123 1 5 HELIX 4 AA4 ASP A 129 GLU A 150 1 22 HELIX 5 AA5 LYS A 158 ALA A 160 5 3 HELIX 6 AA6 VAL A 177 ARG A 188 1 12 HELIX 7 AA7 ALA A 199 GLN A 205 1 7 HELIX 8 AA8 SER A 210 GLY A 227 1 18 HELIX 9 AA9 HIS A 235 ASN A 246 1 12 HELIX 10 AB1 SER A 256 LEU A 267 1 12 HELIX 11 AB2 GLU A 270 ARG A 274 5 5 HELIX 12 AB3 THR A 276 LEU A 281 1 6 HELIX 13 AB4 HIS A 283 ALA A 290 1 8 HELIX 14 AB5 LYS A 292 TYR A 295 5 4 HELIX 15 AB6 LEU A 296 HIS A 308 1 13 SHEET 1 AA1 5 PHE A 36 GLY A 45 0 SHEET 2 AA1 5 GLY A 48 ASP A 55 -1 O LYS A 52 N LEU A 39 SHEET 3 AA1 5 LYS A 60 ASP A 68 -1 O ILE A 64 N PHE A 51 SHEET 4 AA1 5 LYS A 106 MET A 111 -1 O ILE A 109 N LYS A 65 SHEET 5 AA1 5 TYR A 97 LYS A 103 -1 N TYR A 101 O TRP A 108 SHEET 1 AA2 3 GLY A 117 SER A 118 0 SHEET 2 AA2 3 VAL A 162 LEU A 164 -1 O LEU A 164 N GLY A 117 SHEET 3 AA2 3 VAL A 170 LEU A 172 -1 O LYS A 171 N LEU A 163 CRYST1 38.127 79.753 100.537 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026228 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012539 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009947 0.00000